- Home
- KROS vs NHC Comparison
KROS vs NHC Comparison
Compare KROS & NHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- NHC
- Stock Information
- Founded
- KROS 2015
- NHC 1971
- Country
- KROS United States
- NHC United States
- Employees
- KROS N/A
- NHC N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- NHC Hospital/Nursing Management
- Sector
- KROS Health Care
- NHC Health Care
- Exchange
- KROS Nasdaq
- NHC Nasdaq
- Market Cap
- KROS 1.8B
- NHC 1.7B
- IPO Year
- KROS 2020
- NHC N/A
- Fundamental
- Price
- KROS $56.62
- NHC $126.08
- Analyst Decision
- KROS Strong Buy
- NHC
- Analyst Count
- KROS 8
- NHC 0
- Target Price
- KROS $91.43
- NHC N/A
- AVG Volume (30 Days)
- KROS 383.1K
- NHC 46.9K
- Earning Date
- KROS 11-06-2024
- NHC 11-08-2024
- Dividend Yield
- KROS N/A
- NHC 1.94%
- EPS Growth
- KROS N/A
- NHC 174.32
- EPS
- KROS N/A
- NHC 7.98
- Revenue
- KROS $651,000.00
- NHC $1,223,271,000.00
- Revenue This Year
- KROS $1,232.45
- NHC N/A
- Revenue Next Year
- KROS $126.39
- NHC N/A
- P/E Ratio
- KROS N/A
- NHC $15.77
- Revenue Growth
- KROS 8037.50
- NHC 10.74
- 52 Week Low
- KROS $27.31
- NHC $73.90
- 52 Week High
- KROS $73.00
- NHC $138.49
- Technical
- Relative Strength Index (RSI)
- KROS 38.94
- NHC 51.62
- Support Level
- KROS $65.54
- NHC $129.12
- Resistance Level
- KROS $70.26
- NHC $136.86
- Average True Range (ATR)
- KROS 3.17
- NHC 4.68
- MACD
- KROS -0.64
- NHC 0.63
- Stochastic Oscillator
- KROS 9.07
- NHC 52.51
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About NHC National HealthCare Corporation
National Healthcare Corp Provides long-term care facilities. Its principal business includes the operation of skilled nursing facilities, assisted living facilities, independent living facilities, and home care programs. The company's activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer's care, senior living services, and home health care services. In addition, the company also provides management services, accounting, and financial services, as well as insurance services to third-party operators of healthcare facilities. Its reportable segments include Inpatient services, and Home care hospice services. Generating, a majority of its revenue from Inpatient services.